PPIRE10299

Target Protein Information
Protein_Name None
Protein_Sequence LVSIRVGGQIKEALLDTGADDTVLEEVNLPGKWKPKMIGGIGGFIKVRQYDQIPIEICGKKAIGTVLVGPTPINIIGRNMLTQLGCTLNFPISPIETVPVKLKPGMDGPK
Organism_Source Human immunodeficiency virus type 1
Functional_Classification aspartic proteases
Cellular_Localization Cytoplasm
Gene_Names pol
UniProt_ID M1KCG9
Protein-Protein Interaction Networks
Peptide Basic Information
Peptide_Name compound 21
Peptide_Sequence XAV
Peptide_Length 3
Peptide_SMILES CC(C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)O
Chemical_Modification X1=2-O-benzyloxy-5-hydroxy-4-oxahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane
Cyclization_Method None
Linear/Cyclic Linear
N-terminal_Modification Free
C-terminal_Modification Free
Amino_Acid_Distribution
Peptide Physicochemical
Molecular_Weight 245.28
Aliphatic_Index 130.00000
Aromaticity 0.00000
Average_Rotatable_Bonds 2.00000
Charge_at_pH_7 -0.00202
Isoelectric_Point 6.10000
Number_of_Hydrogen_Bond_Acceptors 4
Number_of_Hydrogen_Bond_Donors 4
Topological_Polar_Surface_Area 121.52000
X_logP_energy -1.32480
Interaction Information
Affinity IC50=60 uM
Affinity_Assay Enzyme Inhibition Kinetics
PDB_ID None
Type Inhibitor
Structure
Reference Information
Document_Type Research Articles
Title Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors.
Release_Year 2012
PMID 21982718
DOI 10.1016/j.bioorg.2011.08.002